AINewsnow

Orakl Oncology Raises $34M Series A to Expand AI Cancer Drug Prediction

Orakl Oncology raised an oversubscribed $34 million Series A co-led by Norrsken VC and Singular on November 12, 2026, bringing its total funding to $50 million to expand its AI cancer drug prediction platform.

Read the full story at Unite.AI ↗

Timeline · 2 reports

  1. 2026-11-12 17:31 · The Next Web
    Orakl Oncology raises $34M to predict cancer drug results with AI
  2. 2026-11-12 17:05 · Unite.AI
    Orakl Oncology Raises $34M Series A to Expand AI Cancer Drug Prediction

More stories

  1. AI accounting startup Sumary raises $25M seed round to expand across Europe — Tech.eu
  2. Sumary raises $25M seed round for AI accounting software — The Next Web
  3. AI accounting startup Sumary raises $25m seed round — Sifted
  4. Nvidia CEO Jensen Huang resigns amid affair reports; Colette Kress seen as successor — CSET Georgetown
  5. Anthropic launches Claude Fable 5.2, topping benchmarks and drawing developer comparisons — Anthropic (X)
  6. AWS releases local emulator of 200+ services written entirely by AI agents — AWS Machine Learning Blog
  7. Google DeepMind launches AlphaGenome 2 to predict genetic variant effects by cell type — Google DeepMind Blog
  8. Google DeepMind's AlphaProof Code formally verifies Signal's cryptographic code in four weeks — Google DeepMind Blog

Get the daily brief of stories like this at 6:30 every morning →